clodronic acid has been researched along with Cancer of the Thyroid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KH; Chi, CW; Chiou, SH; Chou, YC; Lee, CH; Lee, TK; Teng, HC; Tsai, ML; Yang, DM | 1 |
| Chang, JW; Hsieh, JJ; Shen, YC; Wang, CH; Yeh, KY | 1 |
2 other study(ies) available for clodronic acid and Cancer of the Thyroid
| Article | Year |
|---|---|
Clodronate-induced cell apoptosis in human thyroid carcinoma is mediated via the P2 receptor signaling pathway.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Purinergic P2; Signal Transduction; Thyroid Neoplasms | 2009 |
Clodronate alleviates cachexia and prolongs survival in nude mice xenografted with an anaplastic thyroid carcinoma cell line.
Topics: Animals; Apoptosis; Cachexia; Carcinoma; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Granulocyte Colony-Stimulating Factor; Interleukin-6; Leukemia Inhibitory Factor; Liver; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Thyroid Neoplasms; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2006 |